Загрузка...
Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate Lyase
Bempedoic acid (ETC-1002), a novel therapeutic approach for low-density lipoprotein cholesterol (LDL-C) lowering, inhibits ATP citrate lyase (ACL), an enzyme involved in fatty acid and cholesterol synthesis. Although rodent studies suggested potential effects of ACL inhibition on both fatty acid and...
Сохранить в:
| Опубликовано в: : | Curr Atheroscler Rep |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer US
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5035316/ https://ncbi.nlm.nih.gov/pubmed/27663902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11883-016-0611-4 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|